MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 275 filers reported holding MYRIAD GENETICS INC in Q4 2013. The put-call ratio across all filers is 4.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $43 | -38.6% | 2,656 | -11.6% | 0.00% | – |
Q2 2023 | $70 | -28.6% | 3,003 | -28.5% | 0.00% | -100.0% |
Q1 2023 | $98 | +60.7% | 4,198 | -0.0% | 0.00% | – |
Q4 2022 | $61 | -99.9% | 4,200 | -2.1% | 0.00% | -100.0% |
Q3 2022 | $82,000 | +24.2% | 4,291 | +17.8% | 0.00% | 0.0% |
Q2 2022 | $66,000 | -25.0% | 3,643 | +4.6% | 0.00% | 0.0% |
Q1 2022 | $88,000 | -11.1% | 3,484 | -2.6% | 0.00% | 0.0% |
Q4 2021 | $99,000 | -3.9% | 3,576 | +6.0% | 0.00% | 0.0% |
Q2 2021 | $103,000 | 0.0% | 3,375 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $103,000 | 0.0% | 3,375 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $103,000 | 0.0% | 3,375 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $103,000 | 0.0% | 3,375 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $103,000 | 0.0% | 3,375 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $103,000 | 0.0% | 3,375 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $103,000 | 0.0% | 3,375 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $103,000 | 0.0% | 3,375 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $103,000 | 0.0% | 3,375 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $103,000 | -99.1% | 3,375 | -99.1% | 0.00% | -99.6% |
Q4 2018 | $11,110,000 | -23.3% | 382,177 | +21.3% | 0.28% | -25.1% |
Q3 2018 | $14,488,000 | +37.3% | 314,966 | +11.6% | 0.37% | +6.6% |
Q2 2018 | $10,549,000 | +27.2% | 282,289 | +0.6% | 0.35% | +5.2% |
Q1 2018 | $8,293,000 | -20.1% | 280,639 | -7.1% | 0.33% | -28.4% |
Q4 2017 | $10,375,000 | -23.9% | 302,093 | -19.8% | 0.46% | -28.5% |
Q3 2017 | $13,635,000 | -1.9% | 376,860 | -30.0% | 0.64% | -9.5% |
Q2 2017 | $13,906,000 | +34.7% | 538,159 | +0.1% | 0.71% | +22.1% |
Q1 2017 | $10,326,000 | +25.2% | 537,802 | +8.7% | 0.58% | +15.4% |
Q4 2016 | $8,248,000 | -10.0% | 494,771 | +11.1% | 0.51% | -19.9% |
Q3 2016 | $9,163,000 | +34.6% | 445,261 | +100.1% | 0.63% | +27.2% |
Q2 2016 | $6,810,000 | -12.0% | 222,555 | +7.7% | 0.50% | -26.8% |
Q1 2016 | $7,735,000 | -14.0% | 206,649 | -0.8% | 0.68% | -22.8% |
Q4 2015 | $8,991,000 | +19.5% | 208,327 | +3.8% | 0.88% | +16.0% |
Q3 2015 | $7,525,000 | +25.2% | 200,780 | +13.5% | 0.76% | +31.4% |
Q2 2015 | $6,011,000 | +20.2% | 176,849 | +25.2% | 0.58% | +14.0% |
Q1 2015 | $5,001,000 | +30.8% | 141,261 | +25.8% | 0.51% | +9.1% |
Q4 2014 | $3,824,000 | +5.5% | 112,270 | +19.5% | 0.46% | -11.8% |
Q3 2014 | $3,623,000 | +20.2% | 93,938 | +21.3% | 0.53% | -2.4% |
Q2 2014 | $3,014,000 | +57.1% | 77,446 | +38.0% | 0.54% | +105.7% |
Q1 2014 | $1,919,000 | +242.1% | 56,124 | +111.5% | 0.26% | +197.7% |
Q4 2013 | $561,000 | +39.6% | 26,538 | +55.0% | 0.09% | -16.2% |
Q3 2013 | $402,000 | – | 17,118 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |